(813) 345-4044 | info@floridaaesthetics.com | Mon–Tue & Thu–Fri: 8am–5pm  ·  Wed: 10am–7pm | 1767 S. Kings Ave., Brandon, FL 33511
Weight Loss at Florida Aesthetics Brandon FL

GLP-1 Therapy · Body & Weight · Brandon, FL

Medical Weight Loss
in Brandon, FL

Physician-supervised GLP-1 therapy with semaglutide and tirzepatide, the most clinically effective weight loss medications ever approved, now available through Florida Aesthetics.

15–22%
average body weight lost (clinical)
Weekly
self-injection
FDA
approved medications
About This Treatment

How do semaglutide and tirzepatide work for weight loss?

GLP-1 receptor agonists (semaglutide, tirzepatide) work by mimicking gut hormones that regulate hunger, insulin, and gastric emptying, reducing appetite, improving satiety, and facilitating significant weight loss through a biological mechanism rather than willpower alone.

Semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro, Zepbound) represent a new class of obesity medications with clinical outcomes that rival bariatric surgery. In clinical trials, patients on tirzepatide lost an average of 22% of body weight over 72 weeks, results previously only achievable through surgery.

At Florida Aesthetics, medical weight loss is supervised by our physician and includes monthly check-ins, dose titration, metabolic monitoring, and behavioral coaching. We don't simply write prescriptions, we provide the medical oversight, nutritional guidance, and accountability that makes sustainable weight loss achievable.

What does Medical Weight Loss treat?

  • Obesity (BMI 30+)
  • Overweight (BMI 27+ with comorbidity)
  • Type 2 diabetes weight component
  • Metabolic syndrome
  • Cardiovascular risk reduction
  • PCOS-related weight gain
  • Inflammatory conditions worsened by excess weight

Why patients choose Florida Aesthetics

  • FDA-approved medications
  • Physician supervised monthly
  • Dose titration included
  • Metabolic lab monitoring
  • Nutritional & behavioral guidance
  • Can be paired with body sculpting
Our Programs

Weight Loss Treatment Options

Physician-supervised programs using FDA-approved medications and evidence-based protocols.

GLP-1 · Most Popular
Semaglutide

FDA-approved GLP-1 receptor agonist. Average 15% body weight reduction in clinical trials. Weekly injection.

Learn More →
Dual GIP/GLP-1 · Newest
Tirzepatide

Dual-action GIP/GLP-1 agonist showing up to 22% weight reduction in trials, the most effective FDA-approved option available.

Learn More →
Oral · FDA-Approved
Contrave

FDA-approved oral weight loss medication combining naltrexone and bupropion to reduce appetite and cravings.

Learn More →
Energy · Metabolism
B12/MIC Injections

Weekly vitamin B12 and lipotropic MIC injections to boost energy, support metabolism, and enhance fat burning.

Learn More →
Analysis · Baseline
Body Composition Analysis

Advanced body composition testing to measure fat mass, lean mass, and metabolic rate, the foundation of your personalized weight loss plan.

Learn More →
Transparent Pricing

How much does Medical Weight Loss cost in Brandon, FL?

Medical weight loss is a monthly subscription program that includes medication, physician oversight, lab interpretation, and behavioral support.

Semaglutide Program

Starting dose (0.25mg/week)

$350

per month

  • Weekly semaglutide injection
  • Monthly physician check-in
  • Dose titration included
  • Nutritional guidance
  • Lab review at baseline
Start Semaglutide

Comprehensive Weight Loss

Medication + body sculpting

$800

per month (save on combo)

  • Semaglutide or tirzepatide
  • Monthly body contouring session
  • Full metabolic monitoring
  • Nutrition planning
  • Maximum transformation
Book Comprehensive

Prices do not include lab work (if not already on file). Insurance rarely covers medical weight loss at aesthetic practices, Cherry financing available.

Medical Weight Loss treatment experience
What to Expect

What happens during a Medical Weight Loss appointment?

1
Medical evaluation & lab work (consultation)
Your physician reviews your medical history, current medications, metabolic labs (or orders them), and determines eligibility for GLP-1 therapy. Contraindications are reviewed, GLP-1 agonists are not appropriate for patients with a personal or family history of medullary thyroid carcinoma or MEN 2.
2
Program initiation & first injection (week 1)
You begin at a low starting dose (semaglutide 0.25mg or tirzepatide 2.5mg) to minimize GI side effects during adaptation. Your provider demonstrates injection technique. Many patients self-administer at home after the first supervised injection.
3
Monthly check-ins & dose titration
Every 4 weeks, you meet with your provider to assess weight loss progress, tolerance, and side effects. Dose is titrated upward per protocol until you reach your optimal therapeutic dose (typically semaglutide 1.0–2.4mg or tirzepatide 5–15mg). Labs are repeated periodically to monitor metabolic health.
4
Maintenance & transition planning
Once your weight loss goal is achieved, your provider discusses maintenance options, tapering, lower-dose maintenance, or discontinuation with monitoring. Lifestyle and behavioral modifications are reinforced throughout the program to maximize sustained results after medication.
Real Results

Medical Weight Loss Before & After

Unretouched photos from real Florida Aesthetics patients. Individual results vary.

Before 30 lbs lost, 6 monthsBefore
After 30 lbs lost, 6 monthsAfter
30 lbs lost, 6 months
Semaglutide program
Before 45 lbs lost, 9 monthsBefore
After 45 lbs lost, 9 monthsAfter
45 lbs lost, 9 months
Tirzepatide program
Before Metabolic improvementBefore
After Metabolic improvementAfter
Metabolic improvement
A1c reduction at 6 months

Individual results vary. All photos are unretouched and represent typical outcomes.

Weight Loss Options Compared

How does Medical Weight Loss compare to alternatives?

Understanding the landscape of medical weight management.

OptionSemaglutideTirzepatideBariatric Surgery
MechanismGLP-1 receptor agonistDual GLP-1/GIP agonistAnatomical restriction/malabsorption
Avg. weight loss15% body weight22% body weight30–40% (sleeve/bypass)
FDA approved Yes (Wegovy 2021) Yes (Zepbound 2023)Procedures vary
InvasivenessWeekly injection (non-surgical)Weekly injection (non-surgical)Major surgery
Side effectsGI nausea, possible hair lossGI nausea (slightly more)Significant surgical risks
Reversible Yes (stop medication) Yes (stop medication)Partially (some procedures)
At FA Yes YesNot offered
Common Questions

Medical Weight Loss, Frequently Asked Questions

FDA-approved criteria: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, high cholesterol, sleep apnea, or cardiovascular disease). Candidates must not have a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2). A full medical review is required before starting.
Most common: nausea, vomiting, diarrhea, and constipation, particularly during the first weeks as doses are escalated. Starting at low doses and titrating slowly minimizes these. Less common: fatigue, decreased appetite (expected), mild hair thinning (typically temporary). Rare serious: pancreatitis, gallbladder disease, kidney injury (from dehydration). All patients receive thorough counseling on side effects and monitoring protocols.
Most patients notice reduced appetite within the first 1–2 weeks. Meaningful weight loss (5–10 lbs) typically occurs in the first month. The best results accumulate over 3–6 months as doses are optimized. Clinical trials show 15–22% body weight loss over 68–72 weeks. Florida Aesthetics patients are monitored monthly to optimize both safety and efficacy.
This is the most important honest conversation in medical weight loss: GLP-1 medications treat obesity as a chronic condition. When medication is stopped, hunger hormones typically return and weight regain is common (average ~10–15% of weight lost regained within a year without continued intervention). Long-term success requires either ongoing medication maintenance or significant lifestyle changes to sustain. Your physician will discuss long-term strategy with you.
Semaglutide is the active ingredient in both Ozempic (approved for type 2 diabetes, 0.5–2mg/week) and Wegovy (approved for weight loss, up to 2.4mg/week). Tirzepatide is the active ingredient in both Mounjaro (diabetes) and Zepbound (weight loss). Florida Aesthetics prescribes FDA-approved semaglutide and tirzepatide through licensed compounding pharmacies or branded products based on availability and patient preference.
Yes, and many patients do. GLP-1 medications reduce overall body fat; body sculpting treatments like Kybella can target specific stubborn deposits (like the submental area) that persist even with significant weight loss. The comprehensive weight loss program at Florida Aesthetics pairs GLP-1 therapy with aesthetic treatments for a more complete transformation.

Ready to Book?

Start with a free consultation, no obligation

We'll evaluate your goals, explain exactly what Medical Weight Loss can and can't achieve for you, and provide a personalized treatment plan with transparent pricing.